We also found that some of these genes have been used as diagnostic biomarkers for CRC and other types of tumors; in particular, overexpression of Tagln is associated with the progression of colon cancer and may serve as a new biomarker for predicting the progression and prognosis of CRC [26, 53]. Here, TAGLN is linked to colonic neoplasm.